These results together with those of the therapeutic effect against the tumors (Fig. 6A,B) suggest that kenpaullone could get into the brain tumor with TMZ, and GSK3β inhibition might be the important mechanism for enhancing the effects of TMZ. The gene discussed is GSK3B; the disease is brain neoplasm.